Literature DB >> 33745965

Investigation of NH3 as a selective thyroid hormone receptor modulator in larval zebrafish (Danio rerio).

Kyla M Walter1, Latika Singh2, Vikrant Singh3, Pamela J Lein4.   

Abstract

Thyroid hormones (THs) are essential for normal vertebrate development and diverse environmental chemicals are hypothesized to cause developmental toxicity by disrupting TH-mediated signaling. The larval zebrafish (Danio rerio) is an emerging in vivo model of developmental TH disruption; however, the effects of TR antagonism have not yet been studied in zebrafish. NH3, generally considered a potent and specific thyroid hormone receptor (TR) antagonist, has been used in rodents and Xenopus laevis to characterize phenotypes of TR antagonism. The objective of this study is to determine the effects of NH3 on endpoints previously determined to be TH-sensitive in larval zebrafish, specifically teratology and mortality, photomotor behavior, and mRNA expression of TH signaling genes. Zebrafish embryos were exposed to NH3 via static waterborne exposure at concentrations ranging from 0.001 to 10 μM beginning at 6 h post-fertilization (hpf) through 5 days post fertilization (dpf). Significant mortality and teratogenesis was observed at 3, 4, and 5 dpf in zebrafish exposed to NH3 at 10 μM. At concentrations that did not cause significant mortality, NH3 did not exert a consistent antagonistic effect on photomotor behavior assays or mRNA expression when administered alone or in the presence of exogenous T4. Rather, depending on the NH3 concentration and larval age NH3 decreased or increased swimming triggered by transition from light to dark. Similarly, inconsistent antagonistic and agonistic effects on mRNA expression of TH signaling genes were noted following treatment with NH3 alone. NH3 did inhibit T4 (30 nM)-induced gene expression; however, this was only consistently observed at a concentration of NH3 (10 μM) that also caused significant mortality. Collectively, these results suggest that NH3 does not act solely as a TR antagonist in larval zebrafish, but instead exhibits complex modulatory effects on TR activity. These data support the hypothesis that NH3 is a selective thyroid hormone receptor modulator. Further studies of NH3 interactions with the zebrafish thyroid hormone receptor are required to characterize the activity of NH3 in target tissues of the larval zebrafish at the molecular level, highlighting the importance of characterizing NH3 effects in specific models of TH-disruption to better interpret its actions in mechanistic screens of environmental chemicals for TH action.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antagonist; Gene expression; Photomotor behavior; Thyroid hormone; Zebrafish

Mesh:

Substances:

Year:  2021        PMID: 33745965      PMCID: PMC8119357          DOI: 10.1016/j.neuro.2021.03.003

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  39 in total

Review 1.  Thyroid effects of endocrine disrupting chemicals.

Authors:  Malene Boas; Ulla Feldt-Rasmussen; Katharina M Main
Journal:  Mol Cell Endocrinol       Date:  2011-09-10       Impact factor: 4.102

2.  Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment.

Authors:  Ngoc-Ha Nguyen; James W Apriletti; Suzana T Cunha Lima; Paul Webb; John D Baxter; Thomas S Scanlan
Journal:  J Med Chem       Date:  2002-07-18       Impact factor: 7.446

3.  Quantitative proteomics of the thyroid hormone receptor-coregulator interactions.

Authors:  Jamie M R Moore; Sarah J Galicia; Andrea C McReynolds; Ngoc-Ha Nguyen; Thomas S Scanlan; R Kiplin Guy
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

4.  Evaluation of embryotoxicity using the zebrafish model.

Authors:  Lisa Truong; Stacey L Harper; Robert L Tanguay
Journal:  Methods Mol Biol       Date:  2011

5.  New synthetic routes to thyroid hormone analogs: d6-sobetirome, 3H-sobetirome, and the antagonist NH-3.

Authors:  Andrew T Placzek; Thomas S Scanlan
Journal:  Tetrahedron       Date:  2015-05-20       Impact factor: 2.457

6.  Implication of thyroid hormone signaling in neural crest cells migration: Evidence from thyroid hormone receptor beta knockdown and NH3 antagonist studies.

Authors:  Odile J Bronchain; Albert Chesneau; Anne-Hélène Monsoro-Burq; Pascale Jolivet; Elodie Paillard; Thomas S Scanlan; Barbara A Demeneix; Laurent M Sachs; Nicolas Pollet
Journal:  Mol Cell Endocrinol       Date:  2016-09-10       Impact factor: 4.102

7.  Advanced morphological - behavioral test platform reveals neurodevelopmental defects in embryonic zebrafish exposed to comprehensive suite of halogenated and organophosphate flame retardants.

Authors:  Pamela D Noyes; Derik E Haggard; Greg D Gonnerman; Robert L Tanguay
Journal:  Toxicol Sci       Date:  2015-02-23       Impact factor: 4.849

8.  Pharmacological profile of the thyroid hormone receptor antagonist NH3 in rats.

Authors:  Gary J Grover; Celeste Dunn; Ngoc-Ha Nguyen; Jamie Boulet; Gao Dong; Jason Domogauer; Peter Barbounis; Thomas S Scanlan
Journal:  J Pharmacol Exp Ther       Date:  2007-04-17       Impact factor: 4.030

9.  BDE-99 impairs differentiation of human and mouse NPCs into the oligodendroglial lineage by species-specific modes of action.

Authors:  Katharina Dach; Farina Bendt; Ulrike Huebenthal; Susanne Giersiefer; Pamela J Lein; Heike Heuer; Ellen Fritsche
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

Review 10.  Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes.

Authors:  Mark D Miller; Kevin M Crofton; Deborah C Rice; R Thomas Zoeller
Journal:  Environ Health Perspect       Date:  2009-02-12       Impact factor: 9.031

View more
  1 in total

1.  Triiodothyronine or Antioxidants Block the Inhibitory Effects of BDE-47 and BDE-49 on Axonal Growth in Rat Hippocampal Neuron-Glia Co-Cultures.

Authors:  Hao Chen; Rhianna K Carty; Adrienne C Bautista; Keri A Hayakawa; Pamela J Lein
Journal:  Toxics       Date:  2022-02-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.